Monopar Therapeutics, Inc. (MNPR)
114.11
-0.27
(-0.24%)
USD |
NASDAQ |
Sep 09, 14:40
Monopar Therapeutics Price to Book Value : 5.853 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 5.867 |
| September 04, 2026 | 6.030 |
| September 03, 2026 | 6.081 |
| September 02, 2026 | 5.965 |
| September 01, 2026 | 6.031 |
| August 31, 2026 | 5.741 |
| August 28, 2026 | 5.739 |
| August 27, 2026 | 5.844 |
| August 26, 2026 | 5.833 |
| August 25, 2026 | 5.684 |
| August 24, 2026 | 5.712 |
| August 21, 2026 | 5.526 |
| August 20, 2026 | 5.688 |
| August 19, 2026 | 6.352 |
| August 18, 2026 | 6.107 |
| August 17, 2026 | 5.975 |
| August 14, 2026 | 5.798 |
| August 13, 2026 | 5.664 |
| August 12, 2026 | 5.894 |
| August 11, 2026 | 5.871 |
| August 10, 2026 | 5.968 |
| August 07, 2026 | 6.115 |
| August 06, 2026 | 6.166 |
| August 05, 2026 | 6.116 |
| August 04, 2026 | 6.076 |
| Date | Value |
|---|---|
| August 03, 2026 | 5.727 |
| July 31, 2026 | 5.558 |
| July 30, 2026 | 5.882 |
| July 29, 2026 | 5.510 |
| July 28, 2026 | 5.596 |
| July 27, 2026 | 5.659 |
| July 24, 2026 | 5.636 |
| July 23, 2026 | 5.422 |
| July 22, 2026 | 5.770 |
| July 21, 2026 | 5.826 |
| July 20, 2026 | 5.432 |
| July 17, 2026 | 5.700 |
| July 16, 2026 | 5.566 |
| July 15, 2026 | 5.575 |
| July 14, 2026 | 5.119 |
| July 13, 2026 | 5.300 |
| July 10, 2026 | 5.468 |
| July 09, 2026 | 5.360 |
| July 08, 2026 | 5.092 |
| July 07, 2026 | 4.884 |
| July 06, 2026 | 4.982 |
| July 02, 2026 | 5.016 |
| July 01, 2026 | 4.875 |
| June 30, 2026 | 4.749 |
| June 29, 2026 | 4.679 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 18.12 |
| Anika Therapeutics, Inc. | 2.050 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.715 |
Price to Book Value Related Metrics
| Price | 114.11 |
| Earnings Yield | -2.05% |
| Market Cap | 765.93M |